Effect of Early Normotension with Olmesartan on Rho-kinase Activity in Hypertensive Patients.

CONCLUSION: Normotension achieved after 9 weeks in 82% of the patients treated with olmesartan was associated with a significant reduction of ROCK activity in PBMC.
PMID: 30663569 [PubMed - as supplied by publisher]

Source: Current Vascular Pharmacology - January 20, 2019 Category: Drugs & Pharmacology Authors: Cantin C, Jalil JE, Bulnes JF, Novoa U, MacNab P, Godoy I, Córdova S, Gabrielli L, Ocaranza MP Tags: Curr Vasc Pharmacol Source Type: research